Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin -4 in the dystrophin deficient mouse
Macromolecule Content Total Structure Weight: 460.38 kDa Atom Count: 36,037 Modeled Residue Count: 4,073 Deposited Residue Count: 4,100 Unique protein chains: 1 Experimental Data Method: X-RAY DIFFRACTION Resolution: 2.01 R-Value Free: 0.192 (Depositor), 0.190 (DCC) R-Value Work: 0.171 (Depositor), 0.168 (DCC) R-Value Observed: 0.171 (Depositor) Unit Cell : Software Package: Revision History (Full details and data files) Version 1.0: 2001-02-23 Type: Initial release Version 1.1: 2011-05-08 Changes: Version format compliance Version 1.2: 2011-07-13 Changes: Version format compliance Version 2.0: 2018-01-17 Changes: Advisory, Atomic model, Data collection, Derived calculations Version 2.1: 2018-02-07 Changes: Source and taxonomy Version 2.2: 2024-05-01 Changes: Advisory, Data collection, Database references, Derived calculations, Refinement description
Despite some trials reporting increased AKI with vancomycin, newer antimicrobials have not consistently shown decreased acute kidney injury risk
Another study involving 28 CDLBP patients compared the clinical outcomes of IRFT (13 patients) to a placebo treatment (15 patients) and found that IRFT was not effective in reducing CDLBP (Barendse et al., 2001)
